 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
Amphotericin B, a systemic antifungal agent, has not been associated with clinical evidence of cardiac toxicity. We report the case of a 76-year-old patient who developed transient asystole with cardiovascular collapse on two occasions, which coincided with infusion of amphotericin B. The patient was semicomatose and had candida septicemia and renal failure. Serum potassium and digoxin levels were elevated, and serum calcium was low when these episodes occurred. Subsequent postmortem examination revealed no gross evidence of cardiac disease apart from fungal vegetations on the aortic valve. A clear causal relationship between amphotericin B and transient asystole is not demonstrated, but a temporal association, confirmed with rechallenge, is documented in this patient. No similar cases were found in a review of the literature.
This article has been cited by other articles:
|
|
 |
|
  D. Burke, R. Lal, K. W Finkel, J. Samuels, and J. R Foringer Acute Amphotericin B Overdose Ann. Pharmacother., December 1, 2006; 40(12): 2254 - 2259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Levy, J. Domaratzki, and G. Koren Amphotericin-Induced Heart-Rate Decrease in Children Clinical Pediatrics, July 1, 1995; 34(7): 358 - 364. [Abstract] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
